Journal article
Peginterferon alpha‐2a versus peginterferon alpha‐2b for chronic hepatitis C
Abstract
BACKGROUND: A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin still represents standard treatment of chronic hepatitis C infection in the majority of patients. However, it is not established which of the two licensed peginterferon products, peginterferon alpha-2a or peginterferon alpha-2b, is the most effective and has a better safety profile.
OBJECTIVES: To systematically evaluate the benefits and harms of …
Authors
Hauser G; Awad T; Thorlund K; Štimac D; Mabrouk M; Gluud C
Journal
Cochrane Database of Systematic Reviews, Vol. 2014, No. 2,
Publisher
Wiley
DOI
10.1002/14651858.cd005642.pub3
ISSN
1361-6137